{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:18:44Z","timestamp":1785147524325,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.thromres.2024.05.006","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T15:25:04Z","timestamp":1715095504000},"page":"223-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Detection and management of clinically relevant drug-drug interactions with direct oral anticoagulants: an intervention study in community pharmacies"],"prefix":"10.1016","volume":"238","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2458-5237","authenticated-orcid":false,"given":"Andreas","family":"Capiau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Mehuys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Grymonprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Van Tongelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Christiaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"Tommelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Philippe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lies","family":"Lahousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Boussery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.thromres.2024.05.006_bb0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.thromres.2024.05.006_bb0010","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/europace\/euab303","article-title":"Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018: a systematic review and meta-analysis","volume":"24","author":"Grymonprez","year":"2022","journal-title":"Europace\u202f: European pacing, arrhythmias, and cardiac electrophysiology\u202f: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology."},{"issue":"4","key":"10.1016\/j.thromres.2024.05.006_bb0015","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/joa3.12588","article-title":"Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world","volume":"37","author":"Kozie\u0142","year":"2021","journal-title":"J Arrhythm"},{"issue":"9921","key":"10.1016\/j.thromres.2024.05.006_bb0020","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.thromres.2024.05.006_bb0025","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European heart rhythm association practical guide on the use of non-vitamin K antagonist Oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace\u202f: European pacing, arrhythmias, and cardiac electrophysiology\u202f: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology."},{"issue":"8","key":"10.1016\/j.thromres.2024.05.006_bb0030","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ehjcvp\/pvad070","article-title":"Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort study","volume":"9","author":"Grymonprez","year":"2023","journal-title":"European heart journal Cardiovascular pharmacotherapy."},{"key":"10.1016\/j.thromres.2024.05.006_bb0035","article-title":"Pharmacodynamic drug-drug interactions and bleeding outcomes in patients with atrial fibrillation using non-vitamin K antagonist Oral anticoagulants: a Nationwide cohort study","author":"Grymonprez","year":"2023","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.thromres.2024.05.006_bb0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.thromres.2020.07.054","article-title":"The increased risk of bleeding due to drug-drug interactions in patients administered direct oral anticoagulants","volume":"195","author":"Lee","year":"2020","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.thromres.2024.05.006_bb0045","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/bcp.14227","article-title":"Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: a population-based nested case-control study","volume":"86","author":"Zhang","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2024.05.006_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.thromres.2023.10.011","article-title":"Co-administered oral anticoagulants with nonsteroidal anti-inflammatory drugs and the risk of bleeding: a systematic review and meta-analysis","volume":"232","author":"Zheng","year":"2023","journal-title":"Thromb. Res."},{"issue":"10","key":"10.1016\/j.thromres.2024.05.006_bb0055","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00002018-200730100-00009","article-title":"The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish prescribed drug register","volume":"30","author":"Johnell","year":"2007","journal-title":"Drug Saf."},{"key":"10.1016\/j.thromres.2024.05.006_bb0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijcard.2020.11.062","article-title":"Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and the EHRA practical guide","volume":"328","author":"Capiau","year":"2021","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"10.1016\/j.thromres.2024.05.006_bb0065","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1111\/bcp.15265","article-title":"Impact of P-glycoprotein and\/or CYP3A4-interacting drugs on effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis","volume":"88","author":"Grymonprez","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.thromres.2024.05.006_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9113568","article-title":"Five-year trends in potential drug interactions with direct-acting Oral anticoagulants in patients with atrial fibrillation: an Australian-wide study","volume":"9","author":"Bezabhe","year":"2020","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.thromres.2024.05.006_bb0075","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11096-022-01511-7","article-title":"Drug-drug interactions with direct oral anticoagulants: development of a consensus list for ambulatory care","volume":"45","author":"Capiau","year":"2023","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.thromres.2024.05.006_bb0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.thromres.2024.05.006_bb0085","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.thromres.2024.05.006_bb0090","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00228-020-03015-7","article-title":"Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants-a Swedish, register-based cohort study in atrial fibrillation outpatients","volume":"77","author":"Holm","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2024.05.006_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.583311","article-title":"Effectiveness and safety of Oral anticoagulants in older patients with atrial fibrillation: a systematic review and Meta-analysis","volume":"11","author":"Grymonprez","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.thromres.2024.05.006_bb0100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0043-1769735","article-title":"The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist Oral anticoagulants in patients with atrial fibrillation","volume":"124","author":"Grymonprez","year":"2024","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2024.05.006_bb0105","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1111\/bcp.15106","article-title":"Physicians\u2019 and pharmacists\u2019 views and experiences regarding use of direct oral anticoagulants in clinical practice","volume":"88","author":"Capiau","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.thromres.2024.05.006_bb0110","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jama.2015.0809","article-title":"Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction","volume":"313","author":"Schjerning Olsen","year":"2015","journal-title":"Jama"},{"issue":"10","key":"10.1016\/j.thromres.2024.05.006_bb0115","doi-asserted-by":"crossref","first-page":"690","DOI":"10.7326\/M13-1581","article-title":"Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study","volume":"161","author":"Lamberts","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2024.05.006_bb0120","unstructured":"National Institute for Health and Care Excellence (NICE). Depression in adults: treatment and management (NG222) 2022. Available from: https:\/\/www.nice.org.uk\/guidance\/ng222\/. Accessed 10 February 2024."},{"issue":"4","key":"10.1016\/j.thromres.2024.05.006_bb0125","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/02813432.2021.2006487","article-title":"Never change a winning team\u2019: GPs\u2019 perspectives on discontinuation of long-term antidepressants","volume":"39","author":"Van Leeuwen","year":"2021","journal-title":"Scand. J. Prim. Health Care"},{"issue":"6","key":"10.1016\/j.thromres.2024.05.006_bb0130","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1080\/17843286.2021.2024384","article-title":"Should I, can I, dare I? Patients\u2019 view on stopping long-term antidepressant use, a qualitative study","volume":"77","author":"Van Leeuwen","year":"2022","journal-title":"Acta Clin. Belg."},{"issue":"2","key":"10.1016\/j.thromres.2024.05.006_bb0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40266-012-0048-6","article-title":"The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review","volume":"30","author":"Kwint","year":"2013","journal-title":"Drugs Aging"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824001609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824001609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T08:41:02Z","timestamp":1716021662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824001609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":27,"alternative-id":["S0049384824001609"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.05.006","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection and management of clinically relevant drug-drug interactions with direct oral anticoagulants: an intervention study in community pharmacies","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}